News
Following FDA encouragement, Faron’s orphan drug gets UK spe...
Faron Pharmaceuticals has been granted a Promising Innovative Medicines (PIM) designation in the UK for its lead product Traumakine, currently in phase 3 trials for Acute Respiratory Distre
